000 01172 a2200325 4500
005 20250517201727.0
264 0 _c20190530
008 201905s 0 0 eng d
022 _a1555-8576
024 7 _a10.1080/15384047.2018.1433495
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTampaki, Ekaterini Christina
245 0 0 _aCabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs.
_h[electronic resource]
260 _bCancer biology & therapy
_c2018
300 _a847-849 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAnilides
650 0 4 _aHumans
650 0 4 _aMitochondria
650 0 4 _aPiperidines
650 0 4 _aPyridines
650 0 4 _aQuinazolines
650 0 4 _aThyroid Neoplasms
700 1 _aTampakis, Athanasios
700 1 _aDroeser, Raoul
700 1 _aPatsouris, Efstratios
700 1 _aKouraklis, Gregory
773 0 _tCancer biology & therapy
_gvol. 19
_gno. 10
_gp. 847-849
856 4 0 _uhttps://doi.org/10.1080/15384047.2018.1433495
_zAvailable from publisher's website
999 _c28084961
_d28084961